Keyphrases
Advanced Ovarian Cancer
100%
Associated Complications
14%
Chemotherapy
42%
Chemotherapy Cycles
14%
Chemotherapy Protocols
14%
Chemotherapy Regimen
100%
Cisplatin
14%
Cytoreductive Surgery
14%
Docetaxel
14%
Early Cessation
14%
Epithelial Ovarian Cancer
14%
FIGO Stage
14%
Gastrointestinal Side Effects
14%
Granulocyte Colony-stimulating Factor (G-CSF)
14%
Hospitalization
14%
Intent-to-treat
14%
Intraperitoneal Chemotherapy
100%
Intraperitoneal Paclitaxel
14%
Neutropenia
14%
Optimal Cytoreductive Surgery
14%
Outpatient Administration
14%
Papillary Serous
14%
Patients Included
14%
Primary Peritoneal Cancer
14%
Reasons for Discontinuation
14%
Residual Disease
14%
Serous Histology
14%
Stage IIIC
14%
Support Measures
14%
Treatment Delay
14%
Treatment-related Mortality
14%
Medicine and Dentistry
Chemotherapy
42%
Chemotherapy Regimens
100%
Cisplatin
14%
Cytoreductive Surgery
28%
Docetaxel
14%
Granulocyte Colony Stimulating Factor
14%
Infection
14%
Intention-to-Treat Analysis
14%
Intraperitoneal Chemotherapy
100%
Krukenberg Tumor
14%
Minimal Residual Disease
14%
Neutropenia
14%
Outpatient
100%
Ovarian Cancer
100%
Paclitaxel
14%
Primary Peritoneal Cancer
14%
Therapy Delay
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
42%
Chemotherapy Regimens
100%
Cisplatin
14%
Docetaxel
14%
Granulocyte Colony Stimulating Factor
14%
Hydration
14%
Infection
14%
Intraperitoneal Chemotherapy
100%
Minimal Residual Disease
14%
Neutropenia
14%
Ovary Cancer
100%
Ovary Carcinoma
14%
Paclitaxel
14%
Peritoneum Cancer
14%